AAO '25: GLP-1s and AMD, and Parity in Retina Care
Update: 2025-11-13
Description
What do GLP-1 receptor agonists mean for the future of retinal disease? Aleksandra Rachitskaya, MD, joins us to review the ever-evolving data on the relationship between retinal disease and GLP-1 RA use. Could these drugs protect against the development of retinal disease? And Julia Haller, MD, explains her vision of what the future of retina looks like. Who needs to be included in the crafting of best practices to ensure that retina specialists offer the highest quality care? Join us on this episode to find out.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
